Cargando…

Correction: Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis

Detalles Bibliográficos
Autores principales:	Fu, Shufang, Wen, Xin, Han, Fei, Long, Yin, Xu, Gaosi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814243/ https://www.ncbi.nlm.nih.gov/pubmed/29465717 http://dx.doi.org/10.18632/oncotarget.24255

Ejemplares similares

Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
por: Fu, Shufang, et al.
Publicado: (2017)

Correction: The optimal time of initiation of renal replacement therapy in acute kidney injury: A meta-analysis
por: Luo, Kaiping, et al.
Publicado: (2018)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

Correction to: Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysis
por: Zou, Honghong, et al.
Publicado: (2019)

Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials
por: Liu, Yukai, et al.
Publicado: (2013)

Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats
por: Pechanova, Olga, et al.
Publicado: (2019)

Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
por: Zou, Honghong, et al.
Publicado: (2018)

Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach
por: Morgado, Manuel P, et al.
Publicado: (2011)

Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2018)

Aliskiren in hypertension: evidence for its potential therapeutic value
por: Peter, Doris
Publicado: (2005)

The optimal time of initiation of renal replacement therapy in acute kidney injury: A meta-analysis
por: Luo, Kaiping, et al.
Publicado: (2017)

Can Aliskiren be Considered as a New Novel Drug for Hypertension?
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015)

Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
por: Hovater, Michael B, et al.
Publicado: (2013)

Correction: Gamma-Glutamyltransferase Level and Risk of Hypertension: A Systematic Review and Meta-Analysis
por: Liu, Cun-Fei, et al.
Publicado: (2013)

Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension
por: Zaporowska-Stachowiak, Iwona, et al.
Publicado: (2013)

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
por: McMurray, John J.V., et al.
Publicado: (2012)

Correction to: METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α‑klotho
por: Li, Manna, et al.
Publicado: (2022)

Aliskiren for heart failure: a systematic review and meta-analysis of randomized controlled trials
por: Liu, Hongzhi, et al.
Publicado: (2017)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Andersen, Karl
Publicado: (2009)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Correction: Association of hypertension with helicobacter pylori: A systematic review and meta‑analysis
por: Fang, Yizhen, et al.
Publicado: (2022)

Correction: Acupuncture Therapy for Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhang, Xin-chang, et al.
Publicado: (2015)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2018)

Aliskiren: An orally active renin inhibitor
por: Wal, Pranay, et al.
Publicado: (2011)

Aliskiren and the dual complement inhibition concept
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients
por: Zheng, Sean L, et al.
Publicado: (2017)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Successful Treatment of Hypertension in Anuric Hemodialysis Patients with a Direct Renin Inhibitor, Aliskiren
por: Maeda, Yoshitaka, et al.
Publicado: (2011)

Correction: Prevalence of Hypertension in Indian Tribes: A Systematic Review and Meta-Analysis of Observational Studies
Publicado: (2014)

Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats
por: Zhang, Wenbin, et al.
Publicado: (2014)

Efficacy and safety of aliskiren combination therapy: a protocol for an umbrella review
por: Shen, Jiantong, et al.
Publicado: (2021)

Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
por: Hasebe, Masashi, et al.
Publicado: (2023)

Role of aliskiren in blood pressure control and renoprotection
por: Trimarchi, Hernán
Publicado: (2011)

Correction: Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis
por: Freedman, Stephen B., et al.
Publicado: (2017)

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
por: Persson, Frederik, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3li9611s79qd64q0o5joun9tt7